Sponsored Content
Sponsored
The emergence of hospital- and community-based MRSA and other resistant gram-positive pathogens have made ABSSSI a critical public health challenge.
As current antibiotics become less effective due to bacterial resistance, there is high demand for new and effective therapies with both IV and oral formulations.
Trending on Contagion Live
1
Analyzing the Data From the ERADICATE Trial of Ceftobiprole vs Daptomycin in Complicated Staphylococcus aureus Bacteremia
2
The Mysterious Contagiousness of the Cruise Ship Strain of the Hantavirus
3
Understanding the Ongoing Ebola Outbreak
4
Anti-HIV CAR-T Cell Therapy Shows Promise in Phase 1/2a Data
5